TABLE 2.
Interactions between lncRNA and mRNAs or miRNAs.
lncRNA |
miRNA |
mRNA |
||||
All | Main targets | EDN | DN | EDN + DN | Targeted function | |
CASC2 | 4 | 1 | 6 | 1 | CC, CA | |
GAS5 | 23 | miR-320c | 7 | 34 | 5 | AP, AG, CC, PL |
H19 | 3 | 11 | 45 | 6 | IF, AP, AG, IM, PL, CC, CA | |
HOTAIR | 14 | 15 | 53 | 10 | IM | |
MALAT1 | 66 | miR-30d-5p, -10a-5p, -29b-3p, -30a-5p, -30e-5p, -320c -638, -572 | 47 | 386 | 29 | AP, IM, PL, PI3K-AKT |
MEG3 | 6 | 5 | 36 | 3 | AG | |
MIAT | 10 | miR-29b-3p | 1 | 7 | 1 | AG, IF |
NEAT1 | 83 | miR-30d-5p, -320c, -29b-3p, -30a-5p, -30e-5p, -10a-5p, -638 | 93 | 755 | 63 | CC, CA, IM, PI3K-AKT |
PVT1 | 7 | 12 | 33 | 8 | PI3K-AKT | |
TUG1 | 47 | miR-30d-5p, -29b-3p, -30a-5p, -30e-5p, -320c | 7 | 59 | 6 | CC, AP, IM, PL, PI3K-AKT |
Table shows the number of identified lncRNA–miRNA and lncRNA–mRNA interactions based on lncRNA related target databases. For targeted function: CC, cell cycle; CA, cell adhesion; AG, angiogenesis; AP, apoptosis; PL, proliferation; IF, inflammation; IM, immune response.